Alberto Santagostino logo

Alberto Santagostino

Description

Alberto Santagostino is a Head of Gene and Cell Therapy at Lonza.

Investor Profile

Alberto Santagostino has made 1 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Seed (100%)

Industry Focus

  • Biotechnology
  • Health Care
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alberto Santagostino frequently co-invest with?

Infinita Fund
North America, Islas de la Bahia, Honduras, Roatán
Co-Investments: 1
Emerging Longevity Ventures
North America, Florida, United States, West Palm Beach
Co-Investments: 1
VitaDAO
North America, Ontario, Canada, Ottawa
Co-Investments: 1
Healthspan Capital
North America, California, United States, El Cerrito
Co-Investments: 1
1517 Fund
North America, California, United States, Oakland
Co-Investments: 1

Which angels does Alberto Santagostino often collaborate with?

Balaji Srinivasan
Asia, Central Region, Singapore, Singapore
Shared Deals: 1
KP
North America, California, United States, San Francisco
Shared Deals: 1
TE
North America, Massachusetts, United States, Boston
Shared Deals: 1
Shared Deals: 1
Shared Deals: 1

What are some of recent deals done by Alberto Santagostino?

ImmuneAGE Bio is a drug discovery platform focused on rejuvenating the immune system.

BiotechnologyHealth Care
SeedJul 12, 2024
Amount Raised: $2,000,000